Crossmark

The Effectiveness of Omalizumab Treatment in Real-Life is Lower in Patients with Chronic Urticaria Longer than 18 Months’ Evolution and Prior Immunosuppressive Treatment

Crossref DOI link: https://doi.org/10.1016/j.adengl.2018.09.015

Published Print: 2019-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Cubiró, X.

Spertino, J.

Rozas-Muñoz, E.

Serra-Baldrich, E.

Puig, L.
License Information

Text and Data Mining valid from 2019-05-01

Version of Record valid from 2020-09-03
More Information

This article is maintained by: Elsevier

Article Title: The Effectiveness of Omalizumab Treatment in Real-Life is Lower in Patients with Chronic Urticaria Longer than 18 Months’ Evolution and Prior Immunosuppressive Treatment

Journal Title: Actas Dermo-Sifiliográficas (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.adengl.2018.09.015

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.ad.2018.09.009

Content Type: article

Copyright: © 2018 Elsevier España, S.L.U. and AEDV. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below